Leadership

Team

Mark Nedelman

Mark Nedelman, MS, MBA

Chief Executive Officer

Striving to be the biggest is not what motivates us. We are driven by a personal quest to serve our clients in every sense as to what that means and requires. We know that their success will ultimately be to the benefit of us all.

Emily Hickey
Emily Hickey, DVM, PhD

Chief Operations Officer

We are devoted to creating relationships with our clients through our valued employees. It is personal to us.

April Hall
April Hall, MS, MBA

Chief Business Officer

Great business partnerships create successful results. Every client, regardless of size, is more than a “study” or another piece of business won. Meeting our clients’ needs is truly personal.

George P. Kustigian Jr
George P. Kustigian Jr, BSBA, CPA

Chief Financial Officer

Assuring we are financially responsible supports competitive pricing. Our clients depend on our expertise as well as our ability to support their budget requirements to expedite their research journeys. Our consistent use of policy, procedure, and process help ensure such.

Daniel Gao
Daniel Gao

CEO of Joinn Lab, Member of Executive Steering Committee of Biomere

AllanGuo
Allan Guo

Strategy Executive, Member of Executive Steering Committee

Extended Team
Laura Belen
Laura Belen

Director of Ophthalmology

Sue Champagne
Sue Champagne

Study Director

Amanda Clark
Amanda Clark

Director, In Vitro Sciences

Deborah Curry

Director of Marketing

Steve Deitz
Steve Deitz

Study Director

Amy Descarreaux
Amy Descarreaux

Client Services and
Alliance Management Lead

Todd Dubreuil
Todd Dubreuil

Study Director

Brendan Fish
Brendan Fish

Study Director

Kristina Guberski
Kristina Guberski

Senior Director of
quality and Compliance

Kari Harbert
Kari Harbert

Study Director

Chris Hogan
Chris Hogan

Senior Director, Program
Operations and Alliances

Ted Ira
Ted Ira

Head of Sales and
Business Development

Leslie Jost
Leslie Jost

Study Director

Lindsay Kist
Lindsay Kist

Study Director

Jean Li
Jean Li

Study Director

Alan LaRochelle
Alan LaRochelle

Senior Program Director,
Large Animal

Elizabeth Olesin
Elizabeth Olesin

Study Director

Kristin Sapp
Kristin Sapp

Director, Genetically Modified
Animal Program

Sarah Webb
Sarah Webb

Study Director

Leadership Bios

Mark Nedelman, MS, MBA

CHIEF EXECUTIVE OFFICER

Mark Nedelman is a drug development and CRO veteran with more than 30 years of experience.

He started his drug development career in the nuclear medicine research laboratory at Massachusetts General Hospital from 1983-87. He was recruited to start and head Preclinical Pharmacology at Centocor, where he was an Associate Director from 1987-1996 playing key roles in the development and approval of numerous first-in-class drugs.

In 1996, Mark joined the CRO industry where he held a number of leadership positions within Charles River Laboratories including being its Senior Director of Pharmacology, Surgery and Toxicology from 2000-2003 and then General Manager of a new, multi-site business unit, Interventional & Surgical Services. He served as a drug development consultant to a number of biotechnology start-ups and has co-authored over 50 peer reviewed publications and 3 book chapters.

Mark holds a B.S. and M.S. in Biology from the University of Cincinnati and a M.B.A. from Northeastern University.

Emily Hickey, DVM, PhD

CHIEF OPERATIONS OFFICER

Emily is a drug-discovery executive with 19 years of experience driving programs from target discovery through clinical development and registration for human and animal health.

She has a Ph.D. in veterinary Medicine from Ohio State University, a doctor of veterinary medicine degree from Virginia-Maryland Regional College of Veterinary Medicine, and a bachelor’s degree from Virginia Polytechnic Institute and State University. As part of the Biomere team, Emily supports our evolution in becoming a leading provider of drug discovery services.

April Hall, MS, MBA

CHIEF BUSINESS OFFICER

April Hall is a veteran of the CRO industry and bioengineer by training. April has over 25 years of experience in pharmaceutical and medical device research. Her experience ranges from primary design and development of orthopaedic devices and bioadhesives to international sales and marketing of testing capabilities and services.

For the past 20 years, April focused on the sales and marketing aspect for preclinical contract research testing. She has led business development efforts at a number of leading contract labs including Charles River Laboratories, Transgenomics and Sinclair Research Center. She serves on the SAB for the Pediatric Medical Device Institute.

April received her B.S. and M.S. from Clemson University and MBA from Northcentral.

George P. Kustigian Jr, BSBA, CPA

CHIEF FINANCIAL OFFICER

George Kustigian is a seasoned financial executive with broad-based business experience. His experience as an audit manager with KPMG has led to financial roles in the manufacturing, construction, non-profit, and biotechnology sectors. Those roles have included Controller, Director, Vice President of Finance, Chief Financial Officer, and Chief Executive Officer. His experience brings a multi-faceted perspective to finance, administration, and planning. In addition, George held positions on the Boards of higher education institutions, trade groups and social service organizations.

George received his B.S.B.A. in both Accounting and Finance from Nichols College. He also earned the designation of Certified Public Accountant from the Commonwealth of Massachusetts.

Daniel Gao

CEO of Joinn Lab, Member of Executive Steering Committee of Biomere

Daniel joined Joinn Laboratories as CFO and Secretory of the Board in 2013. He played a key role to successfully launch Joinn Laboratories at Shanghai stock exchange in 2017. Since 2019, Daniel has been serving as the CEO for Joinn, responsible for company’s operation and management.

Daniel obtained his degree from Central University of Finance and Economic.

Allan Guo

Strategy Executive, Member of Executive Steering Committee

Allan was a former executive director of China Institute at the University of Massachusetts and Senior Advisor to the President of UMass for International Affairs. He is also a distinguished international strategy consultant, advising higher education, business and government organizations in the US and China that are interested in establishing programs, partnerships or business concerns together. He has been instrumental in developing the China initiatives at University of Massachusetts Boston and the University of Massachusetts International strategy. Prior joining the University of Massachusetts, Allan was the Cofounder and Chief Executive Officer of Agiletron Consulting Group (ACG), an international strategy and government relationships consulting firm. He also served for five years as Chief Operating Officer of RCL Computer Ltd., a network and integration company providing technology service in Boston, Vancouver Canada.

Mr. Guo has a Bachelors and Master’s degree in Biology Chemistry from Zhongshan University of China and the University of Toronto. He is a frequent speaker on Chinese culture and history, as well as economic, education and business development in China.